Exhibit 99.1
Joint Filing Agreement
The undersigned hereby agree that the Statement on Schedule 13G dated March 28, 2024 with respect to the Common Stock, par value $0.01 per share, of Outlook Therapeutics, Inc., and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
Dated: March 28, 2024
Velan Capital Master Fund LP | |||
By: | Velan Capital Holdings LLC General Partner | ||
By: | /s/ Adam Morgan | ||
Name: | Adam Morgan | ||
Title: | Managing Member |
Velan Capital Holdings LLC | |||
By: | /s/ Adam Morgan | ||
Name: | Adam Morgan | ||
Title: | Managing Member |
Velan Capital Investment Management LP | |||
By: | Velan Capital Management LLC General Partner | ||
By: | /s/ Adam Morgan | ||
Name: | Adam Morgan | ||
Title: | Managing Member |
Velan Capital Management LLC | |||
By: | /s/ Adam Morgan | ||
Name: | Adam Morgan | ||
Title: | Managing Member |
/s/ Adam Morgan | |
Adam Morgan |
/s/ Balaji Venkataraman | |
Balaji Venkataraman |